BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palmiero G, Cesaro A, Vetrano E, Pafundi PC, Galiero R, Caturano A, Moscarella E, Gragnano F, Salvatore T, Rinaldi L, Calabrò P, Sasso FC. Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects. Int J Mol Sci 2021;22:5863. [PMID: 34070765 DOI: 10.3390/ijms22115863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Althobaiti FM, Alsanosi SM, Falemban AH, Alzahrani AR, Fataha SA, Salih SO, Alrumaih AM, Alotaibi KN, Althobaiti HM, Al-ghamdi SS, Ayoub N. Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study. JCM 2022;11:4769. [DOI: 10.3390/jcm11164769] [Reference Citation Analysis]
2 Koniari I, Velissaris D, Kounis NG, Koufou E, Artopoulou E, de Gregorio C, Mplani V, Paraskevas T, Tsigkas G, Hung M, Plotas P, Lambadiari V, Ikonomidis I. Anti-Diabetic Therapy, Heart Failure and Oxidative Stress: An Update. JCM 2022;11:4660. [DOI: 10.3390/jcm11164660] [Reference Citation Analysis]
3 Sanz-Cánovas J, López-Sampalo A, Cobos-Palacios L, Ricci M, Hernández-Negrín H, Mancebo-Sevilla JJ, Álvarez-Recio E, López-Carmona MD, Pérez-Belmonte LM, Gómez-Huelgas R, Bernal-López MR. Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia. Int J Environ Res Public Health 2022;19:8677. [PMID: 35886528 DOI: 10.3390/ijerph19148677] [Reference Citation Analysis]
4 Hanson P, Arkill KP, Merry CL, Hussain MS, Meersmann T, Randeva HS, Pavlovskaya GE, O'Hare P, Barber TM. Novel perspectives of sodium handling in type 2 diabetes mellitus. Expert Rev Endocrinol Metab 2022;:1-9. [PMID: 35729865 DOI: 10.1080/17446651.2022.2092094] [Reference Citation Analysis]
5 Charaya K, Shchekochikhin D, Andreev D, Dyachuk I, Tarasenko S, Poltavskaya M, Mesitskaya D, Bogdanova A, Ananicheva N, Kuzub A. Impact of dapagliflozin treatment on renal function and diuretics use in acute heart failure: a pilot study. Open Heart 2022;9:e001936. [PMID: 35609943 DOI: 10.1136/openhrt-2021-001936] [Reference Citation Analysis]
6 Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Casella G, Mauro C, Vassilev D, Marfella R, Calabrò P, Barbato E, Pizzi C. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovasc Diabetol 2022;21:77. [PMID: 35570280 DOI: 10.1186/s12933-022-01506-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
7 Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis K, Tousoulis D. Pleiotropic effects of SGLT2 inhibitors and heart failure outcomes. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dia M, Leon C, Chanon S, Bendridi N, Gomez L, Rieusset J, Thibault H, Paillard M. Effect of Metformin on T2D-Induced MAM Ca2+ Uncoupling and Contractile Dysfunction in an Early Mouse Model of Diabetic HFpEF. Int J Mol Sci 2022;23:3569. [PMID: 35408928 DOI: 10.3390/ijms23073569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Keller DM, Ahmed N, Tariq H, Walgamage M, Walgamage T, Mohammed A, Chou JT, Kałużna-Oleksy M, Lesiak M, Straburzyńska-Migaj E. SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure-A Concise Review. J Clin Med 2022;11:1470. [PMID: 35329796 DOI: 10.3390/jcm11061470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Matthews JR, Schlaich MP, Rakoczy EP, Matthews VB, Herat LY. The Effect of SGLT2 Inhibition on Diabetic Kidney Disease in a Model of Diabetic Retinopathy. Biomedicines 2022;10:522. [DOI: 10.3390/biomedicines10030522] [Reference Citation Analysis]
11 Al-salmi FA, Hamza RZ. Efficacy of Vanadyl Sulfate and Selenium Tetrachloride as Anti-Diabetic Agents against Hyperglycemia and Oxidative Stress Induced by Diabetes Mellitus in Male Rats. CIMB 2022;44:94-104. [DOI: 10.3390/cimb44010007] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Wang Y. Higher fasting triglyceride predicts higher risks of diabetes mortality in US adults. Lipids Health Dis 2021;20:181. [PMID: 34930280 DOI: 10.1186/s12944-021-01614-6] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
13 Pinto PC, Rönnau C, Burchardt M, Wolff I. Kidney Cancer and Chronic Kidney Disease: Too Close for Comfort. Biomedicines 2021;9:1761. [PMID: 34944574 DOI: 10.3390/biomedicines9121761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Lebedev DA, Lyasnikova EA, Vasilyeva EY, Likhonosov NP, Sitnikova MY, Babenko AY. Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus. J Diabetes Res 2021;2021:9589185. [PMID: 34778465 DOI: 10.1155/2021/9589185] [Reference Citation Analysis]
15 Savarimuthu S, Harky A. The role of sodium-glucose co-transporter 2 protein inhibitors in heart failure: more than an antidiabetic drug? Expert Opin Pharmacother 2021;:1-10. [PMID: 34713764 DOI: 10.1080/14656566.2021.1998458] [Reference Citation Analysis]
16 Winiarska A, Knysak M, Nabrdalik K, Gumprecht J, Stompór T. Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists. Int J Mol Sci 2021;22:10822. [PMID: 34639160 DOI: 10.3390/ijms221910822] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
17 Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study. BMC Cardiovasc Disord 2021;21:386. [PMID: 34372778 DOI: 10.1186/s12872-021-02198-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Lymperopoulos A, Borges JI, Cora N, Sizova A. Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin's Effects in the Adrenal Gland. Int J Mol Sci 2021;22:7684. [PMID: 34299304 DOI: 10.3390/ijms22147684] [Cited by in F6Publishing: 6] [Reference Citation Analysis]